Skip to main content
. 2020 May 21;7(7):ofaa177. doi: 10.1093/ofid/ofaa177

Table 2.

Pooled Adjusted VE for All Patients (Irrespective of Age)

Influenza Types and Subtypes Analyzed Subgroups No. of Studies Pooled VE Across All Seasons (95% CI) I 2 Statistic, % Publication Bias, Egger’s Test P Value
H1N1
Vaccination status: medical records 24 52 (45–58) 32.7 .031
Vaccination status: self-reported 6 62 (46–73) 55.0 N/A
Respiratory specimen swab: ≤7 d 39 54 (49–58) 39.5 .022
Respiratory specimen swab: ≤4 d 7 59 (47–69) 0.0 N/A
Adjusted age 26 57 (51–63) 32.1 .034
Adjusted age & medical conditions 20 53 (46–59) 43.6 .148
H3N2
Vaccination status: medical records 26 25 (15–34) 55.0 .988
Vaccination status: self-reported 5 32 (-0–53) 76.9 N/A
Respiratory specimen swab: ≤7 d 35 28 (22–34) 57.5 .301
Respiratory specimen swab: ≤4 d 8 18 (-26–47) 63.3 N/A
Adjusted age 23 34 (28–40) 11.5 .794
Adjusted age & medical conditions 20 21 (10–30) 70.5 .997
Influenza B
Vaccination status: medical records 26 43 (31–52) 70.3 .701
Vaccination status: self-reported 5 48 (36–59) 28.2 N/A
Respiratory specimen swab: ≤7 d 33 48 (43–53) 28.2 .974
Respiratory specimen swab: ≤4 d 10 38 (4–60) 77.5 .070
Adjusted age 22 50 (44–56) 26.5 .893
Adjusted age & medical conditions 21 40 (27–51) 70.7 .252
All influenza
Vaccination status: medical records 39 43 (35–49) 75.3 .807
Vaccination status: self-reported 7 48 (31–61) 84.5 N/A
Respiratory specimen swab: ≤7 d 56 46 (41–51) 70.6 .152
Respiratory specimen swab: ≤4 d 12 38 (15–55) 77.3 .009
Adjusted age 32 47 (42–52) 56.5 .477
Adjusted age & medical conditions 37 43 (34–51) 79.8 .184

Abbreviations: CI, confidence interval; N/A, not applicable; VE, vaccine effectiveness.